Narcolepsy-cataplexy syndrome
MONDO:0016158A type of narcolepsy characterized by excessive day-time sleepiness associated with uncontrollable sleep urges and cataplexy (loss of muscle tone often triggered by pleasant emotions).
Also known as: Gelineau disease, Gelineau syndrome, Gelineau's syndrome, Gélineau disease, narcolepsy type 1, narcolepsy with cataplexy, narcolepsy-cataplexy syndrome, narcoleptic syndrome
72 clinical trials for this condition and its sub-types, 42 tagged with Narcolepsy-cataplexy syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Narcolepsy-cataplexy syndrome
-
Narcolepsy 1 5 trials
-
Narcolepsy 3 0 trials
-
Narcolepsy 7 0 trials
-
New narcolepsy drug TAK-861 put to the test in withdrawal trial
Disease control OngoingThis study tests whether TAK-861 can control symptoms of narcolepsy type 1, a condition causing sudden sleep attacks and muscle weakness. About 88 adults will take TAK-861 for several months, then some will switch to a placebo to see if symptoms return. The goal is to see if the …
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Radar could replace wires for narcolepsy sleep tests
Diagnosis OngoingThis study tests whether a millimeter-wave radar system can accurately diagnose type 1 narcolepsy by monitoring sleep without physical contact. Forty patients will use the radar alongside standard sleep tests (PSG/MSLT) to see if the radar matches the standard results. If it work…
Sponsor: Xijing Hospital • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Spain launches nationwide narcolepsy count
Knowledge-focused OngoingThis study aims to find out how many people in Spain have been diagnosed with narcolepsy type 1 or type 2, and how many new cases are diagnosed each year. Researchers will review medical records from hospitals across Spain to count patients and understand patterns. No treatment o…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC